Publication | Closed Access
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
171
Citations
14
References
2018
Year
In this large real-world cohort we observed that VDZ was well tolerated and effective in achieving key clinical outcomes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1